Midatech Pharma plc
MTP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $381 | $699 | $578 |
| % Growth | -100% | -45.5% | 20.9% | – |
| Cost of Goods Sold | $5,437 | $4,067 | $5,111 | $4,654 |
| Gross Profit | -$5,437 | -$3,686 | -$4,412 | -$4,076 |
| % Margin | – | -967.5% | -631.2% | -705.2% |
| R&D Expenses | $5,437 | $4,067 | $5,111 | $4,654 |
| G&A Expenses | $3,793 | $4,342 | $4,542 | $2,946 |
| SG&A Expenses | $3,793 | $4,342 | $4,542 | $2,946 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,468 | -$4,081 | -$5,133 | -$4,678 |
| Operating Expenses | $3,762 | $4,328 | $4,520 | $2,922 |
| Operating Income | -$9,199 | -$8,014 | -$8,932 | -$6,998 |
| % Margin | – | -2,103.4% | -1,277.8% | -1,210.7% |
| Other Income/Exp. Net | $3,220 | $529 | $444 | $892 |
| Pre-Tax Income | -$5,979 | -$7,485 | -$8,488 | -$6,106 |
| Tax Expense | -$250 | -$406 | -$832 | -$646 |
| Net Income | -$5,729 | -$7,079 | -$7,656 | -$5,460 |
| % Margin | – | -1,858% | -1,095.3% | -944.6% |
| EPS | -11.57 | -2.29 | -49.43 | -35.25 |
| % Growth | -405.2% | 95.4% | -40.2% | – |
| EPS Diluted | -11.57 | -2.29 | -49.43 | -35.25 |
| Weighted Avg Shares Out | 6,195,231 | 3,098 | 155 | 155 |
| Weighted Avg Shares Out Dil | 6,195,231 | 3,098 | 155 | 155 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $83 | $29 | $0 |
| Interest Expense | $0 | $41 | $53 | $44 |
| Depreciation & Amortization | $117 | $283 | $174 | $403 |
| EBITDA | -$9,082 | -$7,161 | -$8,261 | -$5,659 |
| % Margin | – | -1,879.5% | -1,181.8% | -979.1% |